(Q39649534)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22356636%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

title

The British Association of Dermatologists' Biologic Interventions Register (BADBIR): design, methodology and objectives (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22356636%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22356636%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Nick J Reynolds

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22356636%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

Christopher Griffiths

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22356636%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

author name string

A D Burden

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22356636%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

C E Kleyn

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22356636%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

K McElhone

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22356636%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

C H Smith

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22356636%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

A D Ormerod

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22356636%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

BADBIR Study Group

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22356636%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

language of work or name

English

0 references

publication date

1 March 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22356636%20AND%20SRC:MED&resulttype=core&format=json

British Journal of Dermatology

23 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22356636%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

volume

166

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22356636%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22356636%20AND%20SRC:MED&resulttype=core&format=json

23 January 2020

page(s)

545-554

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22356636%20AND%20SRC:MED&resulttype=core&format=json

Lymphoma rates are low but increased in patients with psoriasis: results from a population-based cohort study in the United Kingdom.

23 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.10835.X

Increased risk for cardiovascular mortality in psoriasis inpatients but not in outpatients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.10835.X

Mortality studies in psoriatic arthritis: results from a single outpatient center. II. Prognostic indicators for death.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.10835.X

Risk of malignancies in psoriasis patients treated with cyclosporine: a 5 y cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.10835.X

Risk of squamous cell carcinoma and methoxsalen (psoralen) and UV-A radiation (PUVA). A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.10835.X

High levels of ultraviolet B exposure increase the risk of non-melanoma skin cancer in psoralen and ultraviolet A-treated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.10835.X

British Association of Dermatologists' guidelines for biologic interventions for psoriasis 2009.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.10835.X

Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.10835.X

Efficacy and safety of infliximab monotherapy for plaque-type psoriasis: a randomised trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.10835.X

A randomized trial of etanercept as monotherapy for psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.10835.X

Efficacy and safety of ustekinumab, a human interleukin-12/23 monoclonal antibody, in patients with psoriasis: 76-week results from a randomised, double-blind, placebo-controlled trial (PHOENIX 1)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.10835.X

Excessive body weight and smoking associates with a high risk of onset of plaque psoriasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.10835.X

Cardiovascular disease and risk factors in patients with psoriasis and psoriatic arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.10835.X

National registries of systemic treatment for psoriasis and the European 'Psonet' initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.10835.X

The British Society for Rheumatology biologics register

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2133.2012.10835.X